These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 17580147

  • 1. A single-dose daclizumab induction protocol in renal allograft recipients: a Chinese single center experience.
    Ji SM, Li LS, Cheng Z, Cheng DR, Sun QQ, Chen JS, Sha GZ, Liu ZH.
    Transplant Proc; 2007 Jun; 39(5):1396-401. PubMed ID: 17580147
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody.
    Beniaminovitz A, Itescu S, Lietz K, Donovan M, Burke EM, Groff BD, Edwards N, Mancini DM.
    N Engl J Med; 2000 Mar 02; 342(9):613-9. PubMed ID: 10699160
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group.
    Vincenti F, Kirkman R, Light S, Bumgardner G, Pescovitz M, Halloran P, Neylan J, Wilkinson A, Ekberg H, Gaston R, Backman L, Burdick J.
    N Engl J Med; 1998 Jan 15; 338(3):161-5. PubMed ID: 9428817
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. WOFIE synergizes with calcineurin-inhibitor treatment and early steroid withdrawal in kidney transplantation.
    Dresske B, Zavazava N, Jenisch S, Exner B, Lenz P, El Mokhtari NE, Kremer B, Faendrich F.
    Transplantation; 2003 Apr 27; 75(8):1286-91. PubMed ID: 12717217
    [Abstract] [Full Text] [Related]

  • 9. Daclizumab is associated with decreased rejection and improved patient survival in renal transplant recipients.
    Morris JA, Hanson JE, Steffen BJ, Chu AH, Chi-Burris KS, Gotz VP, Gordon RD.
    Clin Transplant; 2005 Jun 27; 19(3):340-5. PubMed ID: 15877795
    [Abstract] [Full Text] [Related]

  • 10. Induction therapy after cardiac transplantation: a comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection.
    Carlsen J, Johansen M, Boesgaard S, Andersen CB, Arendrup H, Aldershvilet J, Mortensen SA.
    J Heart Lung Transplant; 2005 Mar 27; 24(3):296-302. PubMed ID: 15737756
    [Abstract] [Full Text] [Related]

  • 11. Use of daclizumab as initial immunosuppression in liver transplant recipients with impaired renal function.
    Emre S, Gondolesi G, Polat K, Ben-Haim M, Artis T, Fishbein TM, Sheiner PA, Kim-Schluger L, Schwartz ME, Miller CM.
    Liver Transpl; 2001 Mar 27; 7(3):220-5. PubMed ID: 11244163
    [Abstract] [Full Text] [Related]

  • 12. Induction therapy in lung transplantation: initial single-center experience comparing daclizumab and antithymocyte globulin.
    Lischke R, Simonek J, Davidová R, Schützner J, Stolz AJ, Vojácek J, Burkert J, Pafko P.
    Transplant Proc; 2007 Mar 27; 39(1):205-12. PubMed ID: 17275507
    [Abstract] [Full Text] [Related]

  • 13. Daclizumab is associated with decreased rejection and no increased mortality in cardiac transplant patients receiving MMF, cyclosporine, and corticosteroids.
    Kobashigawa J, David K, Morris J, Chu AH, Steffen BJ, Gotz VP, Gordon RD.
    Transplant Proc; 2005 Mar 27; 37(2):1333-9. PubMed ID: 15848713
    [Abstract] [Full Text] [Related]

  • 14. Single-shot antithymocyte globuline and daclizumab induction in simultaneous pancreas and kidney transplant recipient: three-year results.
    Schulz T, Flecken M, Kapischke M, Busing M.
    Transplant Proc; 2005 May 27; 37(4):1818-20. PubMed ID: 15919476
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The incidence of acute cellular rejection after lung transplantation: a comparative study of anti-thymocyte globulin and daclizumab.
    Burton CM, Andersen CB, Jensen AS, Iversen M, Milman N, Boesgaard S, Arendrup H, Eliasen K, Carlsen J.
    J Heart Lung Transplant; 2006 Jun 27; 25(6):638-47. PubMed ID: 16730569
    [Abstract] [Full Text] [Related]

  • 17. A prospective, randomized, multicenter study evaluating the safety and efficacy of two dosing regimens of daclizumab compared to no antibody induction in simultaneous kidney-pancreas transplantation: results at 3 years.
    Stratta RJ, Alloway RR, Lo A, Hodge EE.
    Transplant Proc; 2005 Oct 27; 37(8):3531-4. PubMed ID: 16298651
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.